Globe Newswire
Today, HF Fund concluded an auction in which it offered bonds issued by Municipality Credit Iceland plc and owned by HF Fund.
Bids were submitted for LSS150434 in the nominal amount of 6,311 m.kr., with clean prices ranging between 99.350 and 97.641, which is equivalent to a yield ranging between 3.92% and 4.30%. Bids in the nominal amount of 3,065 m.kr. were accepted at a clean price of 98.954, which is equivalent to a yield of 4.01%.
Further information can... (continue reading...)
NEW YORK, June 05, 2024 (GLOBE NEWSWIRE) -- Acreage Holdings, Inc. (“Acreage” or the “Company”) (CSE: ACRG.A.U, ACRG.B.U) (OTCQX: ACRHF, ACRDF), a vertically integrated, multi-state operator of cannabis cultivation and retailing facilities in the U.S., today announced that it has entered into subscription agreements with certain institutional investors (each, an “Investor”) to issue units (the “Units”) by way of a brokered private placement at a price... (continue reading...)
KINGSTOWN, Saint Vincent and the Grenadines, June 05, 2024 (GLOBE NEWSWIRE) -- WOOFi, the premier decentralized perpetual futures exchange, is thrilled to announce the return of ARB incentives, with 395,000 ARB to be distributed to users over the next 12 weeks, courtesy of the Arbitrum DAO’s STIP Bridge proposal. This incentive program is designed to reward users across various WOOFi products, encouraging increased participation and engagement.
Incentive Breakdown:
... (continue reading...)TAIPEI, Taiwan , June 05, 2024 (GLOBE NEWSWIRE) -- TRYX is thrilled to announce its participation in Computex 2024, marking its debut on the international stage with the highly anticipated PANORAMA liquid cooler. Renowned for its exceptional design, TRYX is set to showcase a range of new products at this prestigious event.
PANORAMA makes its debut on the international stage for the first time.
The PANORAMA features a 6.5-inch L-shaped 3D screen with a 2K... (continue reading...)
NEW YORK, June 05, 2024 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM) (Axsome), a biopharmaceutical company developing and delivering novel therapies for the management of central nervous system disorders, today announced that it has entered into a settlement agreement with Unichem Laboratories Ltd. (Unichem) resolving patent litigation related to Axsome’s product Sunosi® (solriamfetol). The litigation, which is pending in the United States District... (continue reading...)
More Globe Newswire
View Older Stories-
Alaska Energy Metals Closes Option to Acquire the Bambino Nickel – Copper Property and Commences Exploration Programs on Its Quebec Properties
-
Pre-Commissioning of Fumed Silica Reactor Pilot Plant Underway
-
Fireweed Launches Largest Regional Exploration Campaign at Macpass
-
Ocular Therapeutix® to Host Investor Day on June 13, 2024
-
Bread Financial™ to Participate in the Morgan Stanley U.S. Financials, Payments & Commercial Real Estate Conference
-
Ollie’s Bargain Outlet Reports First Quarter Fiscal 2024 Financial Results
-
Hydreight in Partnership with DSV Global and VS Digital Health Launches Telemedicine Solution That Helps Companies Launch A D2C Healthcare Brand In All 50 States
-
Ocean Power Technologies Awarded Contract for Immediate Delivery of Unmanned Surface Vehicle to Offshore Construction Contractor
-
MiNK Therapeutics Announces Virtual Annual Shareholders Meeting
-
Bread Financial™ to Participate in the Morgan Stanley U.S. Financials, Payments & Commercial Real Estate Conference
-
Passage Bio to Present at Goldman Sachs 45th Annual Global Healthcare Conference
-
Telix Announces Launch of Proposed Initial Public Offering in the United States
-
Ollie’s Bargain Outlet Announces Executive Promotions and Appointments as Part of Anticipated Leadership Succession
-
Fortuna Announces Offering of Convertible Senior Notes
-
Y-mAbs Deepens Radiopharmaceutical Leadership with Appointment of Norman LaFrance, M.D. as Chief Development Officer
-
Eldorado Gold Announces Election of Directors and Voting Results from Annual Meeting of Shareholders
-
LSL Pharma Group Announces a Combination of Private Placements for Maximum Aggregate Gross Proceeds of $4.5 Million
-
Ocean Biomedical (NASDAQ: OCEA) Congratulates Joint Venture Partner, Virion Therapeutics, on Positive Immunogenicity Results from Their Lead Checkpoint Modifier-Containing Immunotherapy, VRON-0200, fo
-
SummerSeries in Trillium Park Returns at Ontario Place
-
SpringWorks Therapeutics to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference
-
G1 Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
AutoZone Vendor Summit Recognizes Contributions of Top Suppliers
-
Lifeist Sells Australian Vapes
-
West Red Lake Gold Outlines 2024 Madsen Mine Plans
-
Altimmune Presents Data at EASL International Liver Congress™ 2024 Supporting the Disease Modifying Potential and Differentiated Therapeutic Profile of Pemvidutide in Metabolic Dysfunction-Associate
-
Atea Pharmaceuticals Presents Positive Initial Phase 2 Data for Bemnifosbuvir and Ruzasvir Combination for Treatment of Hepatitis C Virus at EASL Congress 2024
-
EyePoint Pharmaceuticals to Present at Goldman Sachs 45th Annual Global Healthcare Conference
-
GXO Releases 2023 ESG Impact Report
-
Amicus Therapeutics to Present at the Goldman Sachs 45th Annual Global Healthcare Conference
-
Krystal Biotech to Present at Goldman Sachs 45th Annual Global Healthcare Conference
-
Instreamatic Announces New Opportunities for Brands to Access Professional Union Talent for Highly Personalized Ads
-
Statement from Bart Demosky, Executive Vice President and CFO, Bombardier, on S&P’s Global Ratings Upgrade from B to B+
-
Lantronix IoT Solution Enables Digital Retail Shelf Signage Solution for HY-LINE Group
-
ArriVent Announces a Multi-Target ADC Collaboration with Alphamab
-
Statement from Bart Demosky, Executive Vice President and CFO, Bombardier, on S&P’s Global Ratings Upgrade from B to B+
-
SPOD Lithium Amends Property Option Agreements and Appoints a New Director
-
ACELYRIN, INC. Announces Positive 16-week Data From its Global Phase 2b/3 Trial of Izokibep in Psoriatic Arthritis to be Shared During Late-Breaking Oral Presentation at EULAR 2024
-
CytoSorbents to Host its 2024 Virtual Annual Stockholders Meeting
-
Amplify ETFs Earns Four Nominations for With Intelligence Mutual Fund and ETF Awards
-
Mesa Regains Compliance with NASDAQ Minimum Bid Price Requirement
-
GeneDx Announces Patient Access Program to Expand Access to Exome Testing for Pediatric Epilepsy Patients
-
PyroGenesis Clears Final Requirement to Becoming Approved Titanium Powder Supplier to Global Aerospace OEM Client
-
Apellis Pharmaceuticals to Host a Fireside Chat at the Goldman Sachs 45th Annual Global Healthcare Conference
-
Cibus to Participate in Upcoming June Investor Events
-
StepStone Closes Largest-Ever Venture Capital Secondaries Fund
-
GXO Releases 2023 ESG Impact Report
-
23andMe Launches New Genetic Report on Bipolar Disorder
-
ECARX Strengthens Strategic Partnership with Tencent to Jointly Develop Intelligent Vehicle Solutions
-
Currency Exchange International to Report its Second Quarter 2024 Results on June 12, 2024, and Host Earnings Conference Call on June 13, 2024 at 8:30 AM EST
-
YieldMax™ ETFs Announces Monthly Distributions on MSTY (106.33%), NVDY (101.82%), CONY (84.85%), YBIT (81.00%), AIYY (78.90%) and Others